The Symposium takes brain health on a time-journey over the pioneering R&D and disruptive technologies that capture and improve brain-plasticity and brain-fitness over a life-time. The scope of the meeting is to foster the exchange between interdisciplinary scientists, technologists and opinion leaders.
Dr Beher will present “OGA inhibitors to target intracellular protein aggregation and neuronal dysfunction in Alzheimer’s and Parkinson’s disease” on November 30th at 5:35pm CET (11:35am EST), at the session II - Technologies of the present.
BrainFit4Life is a non-profit organization composed of world-renowned scientists, clinicians, companies, foundations and patients’ organization who specialize in neurological diseases, particularly brain aging disorders, a major public health issue in Switzerland, and worldwide.
Further information about BrainFit4Life